Matches in SemOpenAlex for { <https://semopenalex.org/work/W2970381778> ?p ?o ?g. }
- W2970381778 endingPage "289" @default.
- W2970381778 startingPage "282" @default.
- W2970381778 abstract "We recently reported that indoleamine 2, 3-dioxygenase (IDO) activity is significantly correlated with more distant metastasis and worse survival. The present study examined whether radiotherapy (RT) dose fractionation correlates with IDO-mediated immune activity in patients with early-stage NSCLC.Methods: Patients with newly diagnosed stage I-II NSCLC treated with either conventionally fractionated 3-dimensional conformal radiotherapy (3DCRT) or stereotactic body radiotherapy (SBRT) were analyzed. Levels of two key molecules associated with the IDO immune checkpoint, serum kynurenine and the kynurenine:tryptophan ratio (K:T ratio), were measured at pre-RT, during-RT, and 3-month post-RT. The relationship between disease control outcomes [overall survival (OS), progression free survival, and local/regional/distant failure rates] and absolute levels of these markers, as well as dynamic changes in their levels during RT, was studied.Fifty-six patients (SBRT = 28, 3DCRT = 28) with early-stage NSCLC were studied. In all patients, higher kynurenine post-RT was significantly associated with worse OS ([HR, 1.25; 95% confidence interval (CI), 1.01-1.55; P = 0.044). No statistically significant differences in absolute kynurenine levels or the K:T ratio were observed in patients treated with 3DCRT or SBRT at any of the three time points. However, the absolute kynurenine levels rose significantly more post-RT in the 3DCRT patients with a median increase 0.721 ng/mL, compared to that of SBRT patients (0.115 ng/mL); P = 0.022.This study validated that elevated IDO activity correlated with worse survival outcomes in patients with early-stage NSCLC treated with definitive RT. Hypofractionated SBRT may have less immunosuppressive effect than 3DCRT, as measured by IDO." @default.
- W2970381778 created "2019-09-05" @default.
- W2970381778 creator A5001104767 @default.
- W2970381778 creator A5016183089 @default.
- W2970381778 creator A5020076697 @default.
- W2970381778 creator A5023651604 @default.
- W2970381778 creator A5050900684 @default.
- W2970381778 creator A5054796938 @default.
- W2970381778 creator A5072230357 @default.
- W2970381778 creator A5087107933 @default.
- W2970381778 creator A5091243183 @default.
- W2970381778 date "2020-01-01" @default.
- W2970381778 modified "2023-10-16" @default.
- W2970381778 title "A Validation Study on IDO Immune Biomarkers for Survival Prediction in Non–Small Cell Lung Cancer: Radiation Dose Fractionation Effect in Early-Stage Disease" @default.
- W2970381778 cites W1908029296 @default.
- W2970381778 cites W1970953269 @default.
- W2970381778 cites W1973594991 @default.
- W2970381778 cites W2023482364 @default.
- W2970381778 cites W2024042262 @default.
- W2970381778 cites W2025421597 @default.
- W2970381778 cites W2028575737 @default.
- W2970381778 cites W2047866259 @default.
- W2970381778 cites W2078161086 @default.
- W2970381778 cites W2080287150 @default.
- W2970381778 cites W2097156202 @default.
- W2970381778 cites W2101760296 @default.
- W2970381778 cites W2122164580 @default.
- W2970381778 cites W2133739473 @default.
- W2970381778 cites W2147268908 @default.
- W2970381778 cites W2166712548 @default.
- W2970381778 cites W2171437874 @default.
- W2970381778 cites W2235523093 @default.
- W2970381778 cites W2315288443 @default.
- W2970381778 cites W2429444364 @default.
- W2970381778 cites W2497169534 @default.
- W2970381778 cites W2618641368 @default.
- W2970381778 cites W2767552162 @default.
- W2970381778 cites W2799838464 @default.
- W2970381778 cites W2888671848 @default.
- W2970381778 cites W2898340040 @default.
- W2970381778 cites W4241827523 @default.
- W2970381778 doi "https://doi.org/10.1158/1078-0432.ccr-19-1202" @default.
- W2970381778 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31471311" @default.
- W2970381778 hasPublicationYear "2020" @default.
- W2970381778 type Work @default.
- W2970381778 sameAs 2970381778 @default.
- W2970381778 citedByCount "19" @default.
- W2970381778 countsByYear W29703817782019 @default.
- W2970381778 countsByYear W29703817782020 @default.
- W2970381778 countsByYear W29703817782021 @default.
- W2970381778 countsByYear W29703817782022 @default.
- W2970381778 countsByYear W29703817782023 @default.
- W2970381778 crossrefType "journal-article" @default.
- W2970381778 hasAuthorship W2970381778A5001104767 @default.
- W2970381778 hasAuthorship W2970381778A5016183089 @default.
- W2970381778 hasAuthorship W2970381778A5020076697 @default.
- W2970381778 hasAuthorship W2970381778A5023651604 @default.
- W2970381778 hasAuthorship W2970381778A5050900684 @default.
- W2970381778 hasAuthorship W2970381778A5054796938 @default.
- W2970381778 hasAuthorship W2970381778A5072230357 @default.
- W2970381778 hasAuthorship W2970381778A5087107933 @default.
- W2970381778 hasAuthorship W2970381778A5091243183 @default.
- W2970381778 hasBestOaLocation W29703817782 @default.
- W2970381778 hasConcept C126322002 @default.
- W2970381778 hasConcept C143998085 @default.
- W2970381778 hasConcept C146357865 @default.
- W2970381778 hasConcept C151730666 @default.
- W2970381778 hasConcept C155806632 @default.
- W2970381778 hasConcept C203014093 @default.
- W2970381778 hasConcept C2776256026 @default.
- W2970381778 hasConcept C2776706248 @default.
- W2970381778 hasConcept C2777503454 @default.
- W2970381778 hasConcept C44249647 @default.
- W2970381778 hasConcept C509974204 @default.
- W2970381778 hasConcept C515207424 @default.
- W2970381778 hasConcept C55493867 @default.
- W2970381778 hasConcept C71924100 @default.
- W2970381778 hasConcept C86803240 @default.
- W2970381778 hasConcept C8891405 @default.
- W2970381778 hasConcept C90924648 @default.
- W2970381778 hasConceptScore W2970381778C126322002 @default.
- W2970381778 hasConceptScore W2970381778C143998085 @default.
- W2970381778 hasConceptScore W2970381778C146357865 @default.
- W2970381778 hasConceptScore W2970381778C151730666 @default.
- W2970381778 hasConceptScore W2970381778C155806632 @default.
- W2970381778 hasConceptScore W2970381778C203014093 @default.
- W2970381778 hasConceptScore W2970381778C2776256026 @default.
- W2970381778 hasConceptScore W2970381778C2776706248 @default.
- W2970381778 hasConceptScore W2970381778C2777503454 @default.
- W2970381778 hasConceptScore W2970381778C44249647 @default.
- W2970381778 hasConceptScore W2970381778C509974204 @default.
- W2970381778 hasConceptScore W2970381778C515207424 @default.
- W2970381778 hasConceptScore W2970381778C55493867 @default.
- W2970381778 hasConceptScore W2970381778C71924100 @default.
- W2970381778 hasConceptScore W2970381778C86803240 @default.
- W2970381778 hasConceptScore W2970381778C8891405 @default.
- W2970381778 hasConceptScore W2970381778C90924648 @default.
- W2970381778 hasFunder F4320337351 @default.